ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,535Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 252

$868K Total Retail Price of All Prescriptions

Rank: 24 out of 252

646 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 646 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 646 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 14,182 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 751 328 S3 1 5
OMEPRAZOLE 699 487 2 6
LEVOTHYROXINE SODIUM 689 553 3 1
FUROSEMIDE 629 487 4 7
LISINOPRIL 567 465 5 3
METOPROLOL TARTRATE 489 409 6 10
GABAPENTIN 483 334 7 11
SIMVASTATIN 471 377 8 2
METFORMIN HCL 450 359 9 9
MELOXICAM 433 274 10 20
AMLODIPINE BESYLATE 428 393 11 4
CITALOPRAM HBR 336 223 12 15
POTASSIUM CHLORIDE 322 229 13 8
ZOLPIDEM TARTRATE 271 165 14 21
NEXIUM 248 139 15 23
TRAMADOL HCL 242 182 16 17
PRAVASTATIN SODIUM 242 198 16 12
WARFARIN SODIUM 236 225 18 14
CLOPIDOGREL 225 184 19 29
ATENOLOL 210 173 20 18
HYDROCHLOROTHIAZIDE 197 183 21 13
RANITIDINE HCL 197 151 21 48
DIOVAN 187 180 23 38
SERTRALINE HCL 178 134 24 27
GLIMEPIRIDE 173 110 25 40
FENTANYL 167 67 S2 26 126
LOVASTATIN 156 143 27 39
ENALAPRIL MALEATE 155 101 28 72
TRAZODONE HCL 149 85 29 31
METOPROLOL SUCCINATE 146 120 30 19
DONEPEZIL HCL 144 115 31 28
PLAVIX 140 117 32 43
AMLODIPINE BESYLATE-BENAZEPRIL 138 73 33 60
PREDNISONE 135 94 34 42
LOSARTAN POTASSIUM 130 126 35 24
FLUOXETINE HCL 127 88 36 57
OXYCODONE HCL 127 67 S2 36 89
SUCRALFATE 123 73 38 125
ALLOPURINOL 122 99 39 30
ADVAIR DISKUS 116 92 40 63
TAMSULOSIN HCL 116 98 40 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 115 88 42 87
ALENDRONATE SODIUM 114 103 43 32
METOCLOPRAMIDE HCL 111 53 44 110
CLONIDINE HCL 111 98 44 35
AMITRIPTYLINE HCL 106 69 R 46 46
ROPINIROLE HCL 105 76 47 84
CIPROFLOXACIN HCL 98 74 48 61
DIGOXIN 98 85 48 44
BENAZEPRIL HCL 97 72 50 80
RISPERIDONE 96 85 51 81
FLUTICASONE PROPIONATE 92 32 52 36
TERAZOSIN HCL 90 90 53 94
PROPRANOLOL HCL 90 54 53 111
CYCLOBENZAPRINE HCL 87 21 R 55 51
CARVEDILOL 85 74 56 22
SINGULAIR 82 55 57 100
VERAPAMIL ER 81 63 58 83
VENLAFAXINE HCL 80 59 59 160
LOSARTAN-HYDROCHLOROTHIAZIDE 79 77 60 49
CRESTOR 78 68 61 34
PROMETHAZINE HCL 77 20 R 62 85
CYMBALTA 77 40 62 45
PROAIR HFA 77 49 62 54
PAROXETINE HCL 76 42 65 75
ATORVASTATIN CALCIUM 75 67 66 16
TRICOR 75 43 66 145
SPIRONOLACTONE 74 71 68 53
KLOR-CON 10 73 68 69 146
VENLAFAXINE HCL ER 71 36 70 105
ISOSORBIDE MONONITRATE ER 70 70 71 50
SYNTHROID 70 62 71 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 52 71 25
LEVOFLOXACIN 70 51 71 79
BUMETANIDE 68 63 75 139
AZITHROMYCIN 68 54 75 37
INSULIN SYRINGE 67 39 77 93
ZETIA 67 61 77 97
POLYETHYLENE GLYCOL 3350 66 58 79 67
TIZANIDINE HCL 66 20 79 129
NOVOLOG 65 27 81 106
DICLOFENAC SODIUM 64 42 82 128
MORPHINE SULFATE ER 63 36 S2 83 127
FENOFIBRATE 63 50 83 64
NAMENDA 63 34 83 41
LANTUS 61 43 86 55
SPIRIVA 57 40 87 68
ESTRADIOL 56 25 R 88 76
MEGESTROL ACETATE 55 48 R 89 138
TRIAMTERENE-HCTZ 55 44 89 33
NAPROXEN 54 27 91 96
ESCITALOPRAM OXALATE 53 38 92 56
MIRTAZAPINE 53 38 92 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.